Continued from front page:
The FDA has a role in preventing surgical fires. FDA regulates the drugs (e.g. oxygen, skin preparation agents) and devices (e.g. ESUs, lasers and surgical drapes) that are components of the fire triangle and reviews product labeling to ensure that appropriate warnings about the risk of fire are included. However, the FDA’s regulatory authorities over the elements of the fire triangle are not sufficient to prevent these accidents.
The FDA is also committed to collaborating with relevant public and private partners to optimize the safe use of the products the agency regulates as part of its Safe Use Initiative. Under the Safe Use Initiative, the FDA convened a meeting with representatives from a variety of healthcare organizations to discuss ways to collaborate to prevent surgical fires. This meeting was an initial step in identifying barriers to safe practices, with the ultimate goal to engage all partners in developing specific, tangible interventions to reduce surgical fires.
As a result of these discussions and follow-up activities, the FDA and its partners launched the “Preventing Surgical Fires” initiative to increase awareness of the risks of surgical fires and promote the adoption of risk reduction practices throughout the healthcare community.
Initial launch Activities: October 13, 2011
· FDA Safety Communication: Preventing Surgical Fires
· Preventing Surgical Fires ite originally housed on FDA website.
· FDA Videos hosted by Medscape (Non-CME and CME)
· FDA Transitioned Preventing Surgical Fires website to CSPS July 2015
Surgical Fires: How They Start and How to Prevent Them – FDA Expert Interview
No registration required. No CME credits are available for this version.